Related references
Note: Only part of the references are listed.Expression of miRNA-29 in Pancreatic β Cells Promotes Inflammation and Diabetes via TRAF3
Yi Sun et al.
CELL REPORTS (2021)
Biomarkers for Point-of-Care Diagnosis of Sepsis
Andrew Teggert et al.
MICROMACHINES (2020)
Hypoxia drives cardiac miRNAs and inflammation in the right and left ventricle
Philippe Chouvarine et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3
Dong Wook Jekarl et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2019)
Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma
Ruihua Fang et al.
DIAGNOSTIC PATHOLOGY (2019)
Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis
Qiongyi Hu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Combatting Sepsis: A Public Health Perspective
Raymund B. Dantes et al.
CLINICAL INFECTIOUS DISEASES (2018)
Circulating miRNA29 family expression levels in patients with essential hypertension as potential markers for left ventricular hypertrophy
Yuqing Huang et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2017)
p53 target miR-29c-3p suppresses colon cancer cell invasion and migration through inhibition of PHLDB2
Geng Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway
Yi-Jun Shu et al.
CELL DEATH AND DIFFERENTIATION (2017)
MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics
J. A. Deiuliis
INTERNATIONAL JOURNAL OF OBESITY (2016)
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis
Carolin Fleischmann et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice
Victoria Ulrich et al.
EMBO MOLECULAR MEDICINE (2016)
Assessment of Clinical Criteria for Sepsis For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Christopher W. Seymour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Meta-analysis of the differentially expressed microRNA profiles in nasopharyngeal carcinoma
Junwen Luan et al.
ONCOTARGET (2016)
Loss of duplexmiR-223 (5p and 3p) aggravates myocardial depression and mortality in polymicrobial sepsis
Xiaohong Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension
Marlene Rabinovitch et al.
CIRCULATION RESEARCH (2014)
MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice
Hai-Yong Chen et al.
MOLECULAR THERAPY (2014)
Presepsin as a novel sepsis biomarker
Qi Zou et al.
WORLD JOURNAL OF EMERGENCY MEDICINE (2014)
MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2
Mitsuhiro Matsuo et al.
MOLECULAR CANCER (2013)
Severe Sepsis and Septic Shock REPLY
Derek C. Angus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Severe Sepsis and Septic Shock
Derek C. Angus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care
Lori F. Gentile et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2012)
Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?
Lien Dejager et al.
TRENDS IN MICROBIOLOGY (2011)
Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γ agonist protects against myocardial ischaemia-reperfusion injury
Yumei Ye et al.
CARDIOVASCULAR RESEARCH (2010)
microRNAs and the immune response
Eleni Tsitsiou et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Share Paper
